Alpha Cognition (NASDAQ:ACOG – Get Free Report) is expected to release its earnings data before the market opens on Wednesday, April 2nd. Analysts expect Alpha Cognition to post earnings of ($1.50) per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.
Alpha Cognition Stock Performance
NASDAQ ACOG opened at $5.53 on Monday. Alpha Cognition has a one year low of $4.66 and a one year high of $7.00. The firm has a market capitalization of $88.59 million, a price-to-earnings ratio of -2.16 and a beta of 2.50. The stock’s 50-day simple moving average is $5.85.
Wall Street Analysts Forecast Growth
A number of research analysts have weighed in on the stock. HC Wainwright began coverage on shares of Alpha Cognition in a research note on Tuesday, March 18th. They issued a “buy” rating and a $20.00 price target on the stock. Raymond James raised Alpha Cognition to a “moderate buy” rating in a research report on Tuesday, March 25th.
About Alpha Cognition
Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Recommended Stories
- Five stocks we like better than Alpha Cognition
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- How to Short a Stock in 5 Easy Steps
- MarketBeat Week in Review – 03/24 – 03/28
- How is Compound Interest Calculated?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for Alpha Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
